Skip to content

Pulse Therapeutics is proud to announce its merger with ICHOR Vascular and the subsequent creation of Euphrates Vascular. For more information, contact CEO Sean Morris.


Euphrates Vascular
20 South Sarah St.
St. Louis, MO 63108

Euphrates Vascular is a growing medical technology company headquartered in St. Louis, Mo. Established in 2008, it is advancing the fight against vascular occlusions, stroke, heart disease and other conditions with its biotech and medtech treatment solutions.

  • This field is for validation purposes and should be left unchanged.